 ThirdAge |
Merck Wins US Approval for Combination Diabetes Treatment
BusinessWeek Oct. 7 (Bloomberg) — Merck & Co. won US approval for a pill that combines the Januvia diabetes medicine with cholesterol treatment Zocor, the first combination of its kind to reduce cholesterol. The Food and Drug Administration … Merck Wins U.S. Approval for Combination Diabetes TreatmentBloomberg FDA Approves Merck's JUVISYNC(TM) (sitagliptin and simvastatin) Tablets, a …MarketWatch (press release) Merck Receives FDA Approval For JUVISYNC For Type 2 Diabetes – Quick FactsRTT News A Sweet Life –ThirdAge –InPharm all 326 news articles » |
More details can be found at www.diabeteshowto.com
Discussion
Comments are disallowed for this post.
Comments are closed.